Kahn S E, Labbé R F, Pfadenhauer E H, Kanonchoff A D, Joseph R T
Department of Pathology, Loyola University Medical Center, Maywood, IL 60153.
Clin Chem. 1994 Sep;40(9):1722-9.
Results of a multicenter evaluation of automated assays for measurement of apolipoproteins (apo) A-I and B with the Paramax analytical system are reported. Apo A-I and apo B response surface models were used to optimize concentrations of critical assay variables. Overall imprecision for apo A-I controls at concentrations of 1.01-1.61 g/L was 3.7-6.6%; overall imprecision for apo B controls at 1.00-1.61 g/L was 2.8-6.9%. There was no interference in apo A-I measurements. Albumin concentrations > 59 g/L resulted in a negative interference, and collection in sodium heparin caused a positive interference in apo B results. Apo A-I and apo B assays demonstrated acceptable agreement with comparative methods, although the Paramax apo B assays had a negative bias with respect to comparison methods. In 116 healthy individuals, serum apo A-I ranged from 0.97 to 2.05 g/L and serum apo B ranged from 0.51 to 1.32 g/L.
报告了使用Paramax分析系统对载脂蛋白(apo)A-I和B进行自动化检测的多中心评估结果。载脂蛋白A-I和载脂蛋白B响应面模型用于优化关键检测变量的浓度。浓度为1.01 - 1.61 g/L的载脂蛋白A-I对照品的总不精密度为3.7% - 6.6%;浓度为1.00 - 1.61 g/L的载脂蛋白B对照品的总不精密度为2.8% - 6.9%。载脂蛋白A-I检测无干扰。白蛋白浓度>59 g/L会导致负干扰,使用肝素钠采集样本会对载脂蛋白B结果产生正干扰。载脂蛋白A-I和载脂蛋白B检测与比较方法显示出可接受的一致性,尽管Paramax载脂蛋白B检测相对于比较方法存在负偏差。在116名健康个体中,血清载脂蛋白A-I范围为0.97至2.05 g/L,血清载脂蛋白B范围为0.51至1.32 g/L。